Its shares have benefited from strong lagging-edge chip ... Past performance is not indicative of future results. Blueprint has an advertiser disclosure policy. The opinions, analyses, reviews ...
InvestorsHub on MSN6d
Boeing Ends Strike; Leadership Changes at Dollar Tree and Southwest; PLTR, HIMS, and ALAB Soar; MQ and LSCC DeclineBoeing workers on the U.S. West Coast ended a seven-week strike after approving a contract that includes a 38% wage increase over four years. The strike, which impacted 737 MAX production and other ...
The firm retained its Sector Perform rating on the stock. The adjustment reflects Vertex's strong performance in its cystic fibrosis (CF) business, which has outperformed expectations. The company ...
William Blair analyst Jake Roberge has maintained their bullish stance on VERX stock, giving a Buy rating today. Jake Roberge has given his ...
Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...
The firm retained its Sector Perform rating on the stock. The adjustment reflects Vertex's strong performance in its cystic fibrosis (CF) business, which has outperformed expectations. The company's ...
This could be influenced by factors such as growth expectations or operational capacity. Revenue Growth: Vertex's remarkable performance in 3 months is evident. As of 30 June, 2024, the company ...
Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback